Pfizer Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	4,951	1,120	366	627.6	1,570
Short-Term Investments	-	22,876	19,153	18,118	15,705	9,494
Cash & Short-Term Investments	27,038	27,826	20,273	18,484	16,332	11,064
Cash Growth	18.52%	37.26%	9.68%	13.17%	47.62%	-49.59%
Accounts Receivable	-	1,931	1,876	1,517	1,426	1,088
Other Receivables	-	209.4	514.4	403.4	874.6	1,909
Receivables	-	2,140	2,391	1,921	2,303	2,998
Inventory	-	4,759	4,337	4,177	4,489	4,351
Prepaid Expenses	-	89.2	80.1	70.4	72.8	50.7
Restricted Cash	-	29.8	45.9	39	74.8	16.5
Other Current Assets	-	283.7	569.5	560.2	342.7	604.7
Total Current Assets	-	35,129	27,696	25,251	23,614	19,085
Property, Plant & Equipment	-	1,795	1,514	1,855	2,201	1,951
Goodwill	-	5,275	5,275	5,275	5,275	5,275
Other Intangible Assets	-	243.1	342.7	442.3	945.5	1,449
Long-Term Deferred Tax Assets	-	693	539.4	976.7	469.8	134.6
Other Long-Term Assets	-	5,977	6,922	6,208	6,496	4,757
Total Assets	-	49,111	42,288	40,007	39,005	32,659
Accounts Payable	-	1,516	1,662	2,171	2,639	2,837
Accrued Expenses	-	662	559.3	1,258	960.3	985.1
Short-Term Debt	-	-	-	-	-	58.2
Current Portion of Long-Term Debt	-	25	25	25	25	25
Current Portion of Leases	-	382.8	376.9	386.5	367.5	607.3
Current Income Taxes Payable	-	2,210	1,601	1,608	1,695	460
Current Unearned Revenue	-	38	566.3	34.8	1,795	1,806
Other Current Liabilities	-	861.7	675.3	1,090	1,048	964.9
Total Current Liabilities	-	5,695	5,466	6,574	8,529	7,743
Long-Term Leases	-	676.2	543.5	933.2	1,277	426.8
Pension & Post-Retirement Benefits	-	-	-	-	56.1	104.7
Other Long-Term Liabilities	-	565.7	323.3	427.6	498.6	453.7
Total Liabilities	-	6,937	6,332	7,934	10,361	8,729
Common Stock	-	457.5	457.5	457.5	457.5	457.5
Additional Paid-In Capital	-	13,207	13,207	13,207	13,207	13,207
Retained Earnings	-	27,378	21,303	17,620	14,354	9,830
Comprehensive Income & Other	-	1,132	988.1	789.1	626	436.7
Shareholders' Equity	38,483	42,174	35,955	32,073	28,644	23,930
Total Liabilities & Equity	-	49,111	42,288	40,007	39,005	32,659
Total Debt	898.3	1,084	945.4	1,345	1,670	1,117
Net Cash (Debt)	26,140	26,742	19,327	17,139	14,663	9,947
Net Cash Growth	18.46%	38.37%	12.77%	16.89%	47.41%	-51.87%
Net Cash Per Share	571.44	584.56	422.48	374.62	320.49	217.42
Filing Date Shares Outstanding	45.74	45.75	45.75	45.75	45.75	45.75
Total Common Shares Outstanding	45.74	45.75	45.75	45.75	45.75	45.75
Working Capital	-	29,433	22,230	18,677	15,086	11,341
Book Value Per Share	841.24	921.88	785.95	701.08	626.13	523.09
Tangible Book Value	33,015	36,656	30,338	26,356	22,424	17,207
Tangible Book Value Per Share	721.71	801.27	663.15	576.11	490.16	376.12
Buildings	-	138.2	132.6	125	125	124.7
Machinery	-	1,139	1,022	839.4	761.3	845.4
Construction In Progress	-	76.4	4	79.3	11.5	27.6
Leasehold Improvements	-	244.4	252.4	307.6	307.7	293.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.